Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Taro Pharmaceuticals
Pharma
Roche, Daiichi-Seagen, LegoChem—Fierce Pharma Asia
Roche posts a positive TIGIT phase 3 result in Asia. Daiichi chalks up a win in its patent fight with Seagen. LegoChem sold a 25% stake to Orion.
Angus Liu
Jan 19, 2024 8:48am
After 17-year courtship, Sun and Taro agree on $348M buyout
Jan 18, 2024 11:23am
Sun Pharma, XtalPi, Yuhan—Fierce Pharma Asia
Jun 2, 2023 1:21pm
Sun ready to complete Taro buyout—16 years after initial offer
May 30, 2023 10:48am
Sun, Eisai, AstraZeneca—Fierce Pharma Asia
Mar 17, 2023 8:00am
Sun settles up in yearslong price-fixing litigation
Mar 14, 2023 11:04am
